tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9

tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9 Struktur
2710294-73-6
CAS-Nr.
2710294-73-6
Englisch Name:
tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9
Synonyma:
tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9;1-Piperidine-2,2,3,3,4,5,5,6,6-d9-carboxylic acid, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thiazolyl-4-d]-, 1,1-dimethylethyl ester
CBNumber:
CB514365536
Summenformel:
C19H21BD10N2O4S
Molgewicht:
404.4
MOL-Datei:
2710294-73-6.mol

tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9 Eigenschaften

Sicherheit

tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9 Chemische Eigenschaften,Einsatz,Produktion Methoden

tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Combiphos (Shanghai) Biological Technology Co., Ltd. 021-65232103 17602124823
combiphos@vip.qq.com China 29909 58

  • tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl-4-d)piperidine-1-carboxylate-2,2,3,3,4,5,5,6,6-d9
  • 1-Piperidine-2,2,3,3,4,5,5,6,6-d9-carboxylic acid, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thiazolyl-4-d]-, 1,1-dimethylethyl ester
  • 2710294-73-6
Copyright 2019 © ChemicalBook. All rights reserved